Not So Fast: Cultivating miRs as Kinks in the Chain of the Cell Cycle

Matthew J Schiewer1, Karen E Knudsen2

  • 1Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA; The Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Cancer Cell
|April 12, 2017
PubMed

Insights

Researchers identified novel cell-cycle-targeting microRNAs that inhibit tumor growth and induce apoptosis. These microRNAs show promise in suppressing chemoresistant cancers and can be predicted using a specific algorithm.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in cancer development.
  • Dysregulation of cell cycle progression is a hallmark of cancer, involving proteins like cyclins and cyclin-dependent kinases (CDKs).
  • Chemotherapy resistance remains a significant challenge in cancer treatment, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To identify and characterize a novel class of microRNAs targeting cell cycle regulators.
  • To evaluate the therapeutic potential of these novel miRNAs in reducing tumor growth and inducing apoptosis.
  • To develop a predictive algorithm for miRNA efficacy in chemoresistant cancers.

Main Methods:

  • Identification and validation of novel microRNAs targeting key cell cycle genes (cyclins/CDKs).
  • In vitro assessment of miRNA-induced tumor cell growth inhibition and apoptosis.
  • In vivo evaluation of miRNA efficacy in patient-derived xenograft models of chemoresistant cancer.
  • Development and validation of an expression-based algorithm for predicting miRNA therapeutic response.

Main Results:

  • A novel class of microRNAs, termed "cell-cycle-targeting miRNAs," was defined.
  • These miRNAs effectively target cyclins and CDKs, leading to reduced tumor cell proliferation and increased apoptosis.
  • Significant suppression of chemoresistant patient-derived xenograft growth was observed in vivo.
  • An expression-based algorithm accurately predicted the efficacy of these miRNAs.

Conclusions:

  • Cell-cycle-targeting miRNAs represent a promising new class of therapeutic agents for cancer treatment.
  • These miRNAs demonstrate efficacy against chemoresistant tumors, offering a potential strategy to overcome treatment resistance.
  • Prospective prediction of miRNA efficacy using a developed algorithm can guide clinical application and patient selection.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Contractile Ring02:15

The Contractile Ring

Contractile rings are composed of microfilaments and are responsible for separating the daughter cells during cytokinesis. Contractile ring assembly proceeds along with other cell cycle events; however, very few mechanistic details are known about the timing and coordination of the contractile rings with the cell cycle.
A small GTPase, RhoA, controls the function and assembly of the contractile ring. RhoA belongs to the Ras superfamily of proteins. The activation of formins by RhoA promotes...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...